Related Experiment Video
Updated: Feb 22, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
A pharmacist-driven academic detailing program to increase adult pneumococcal vaccination
A pharmacist-led campaign improved knowledge of pneumococcal vaccines, increasing vaccination rates and decreasing disease incidence. This initiative highlights the impact of targeted education on public health outcomes.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Vaccinology
Background:
- Pneumococcal immunization recommendations require consistent provider knowledge and patient awareness.
- Pharmacist-led initiatives can bridge gaps in vaccine education and uptake.
Purpose of the Study:
- To describe a statewide, pharmacist-led education campaign aimed at enhancing knowledge and awareness of pneumococcal immunization guidelines.
- To evaluate the impact of this campaign on vaccination rates and pneumococcal disease incidence.
Main Methods:
- Development of a clinical pathway (decision-support tool) for health professionals on pneumococcal vaccine indications and schedules.
- Implementation of academic detailing and community outreach (radio ads, patient materials) across Rhode Island.
- Evaluation through provider surveys and analysis of pneumococcal disease rates before and after the intervention.
Main Results:
- Over 400 practice sites reached, with 92% of surveyed providers reporting improved knowledge of pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
- Significant increase in pneumococcal vaccination rates (absolute difference 3.9%, P = 0.01).
- Significant decrease in pneumococcal disease between pre-intervention and intervention periods (-2.74/10,000 discharges, P = 0.02), with a notable reduction in invasive pneumococcal disease.
Conclusions:
- The pharmacist-driven educational outreach program effectively improved provider knowledge and perceptions regarding pneumococcal vaccination.
- The campaign led to increased vaccination uptake and a significant reduction in pneumococcal disease incidence.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Drug Dosing: Geriatric Patients
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...